CEO: | Stephen O'Hara |
Finance Director: | David Blain |
Non-Executive Chairman: | Neil Davidson |
Research and Development Director: | Sofia Kolyda |
Non-Executive Dir: | Sean Christie |
Address: | 145-147 St John Street, London, EC1V 4PY |
Phone: | + 44 (0) 203 178 5618 |
Website: | http://www.optibiotix.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BP0RTP38 |
Currency | UK Pounds |
Share Price | 10.60p |
Change Today | -0.15p |
% Change | -1.40 % |
52 Week High | 22.60 |
52 Week Low | 10.25 |
Volume | 43,920 |
Shares Issued | 103.30m |
Market Cap | £10.95m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
12:21 | 678 @ 10.51p |
11:59 | 4,629 @ 10.80p |
11:20 | 25,000 @ 10.52p |
09:43 | 13,613 @ 10.53p |
CEO | Stephen O'Hara |
Finance Director | David Blain |
You are here: research